Linezolid resistance in a clinical isolate of Staphylococcus aureus

被引:838
|
作者
Tsiodras, S
Gold, HS
Sakoulas, G
Eliopoulos, GM
Wennersten, C
Venkataraman, L
Moellering, RC
Ferraro, MJ
机构
[1] Massachusetts Gen Hosp, Dept Pathol, Clin Microbiol Labs, Boston, MA 02114 USA
[2] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[4] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
来源
LANCET | 2001年 / 358卷 / 9277期
关键词
D O I
10.1016/S0140-6736(01)05410-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The new oxazolidinone antimicrobial, linezolid, has been approved for the treatment of infections caused by various gram-positive bacteria, including meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE). Although instances of linezolid resistance in VRE have been reported, resistance has not been encountered among clinical isolates of S aureus. We have characterised an MRSA isolate resistant to linezolid that was recovered from a patient treated with this agent for dialysis-associated peritonitis.
引用
下载
收藏
页码:207 / 208
页数:2
相关论文
共 50 条
  • [1] Linezolid resistance in clinical isolates of Staphylococcus aureus
    Wilson, P
    Andrews, JA
    Charlesworth, R
    Walesby, R
    Singer, M
    Farrell, DJ
    Robbins, M
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 186 - 187
  • [2] Linezolid resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis
    Layer, F.
    Cuny, C.
    Strommenger, B.
    Witte, W.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 : 102 - 102
  • [3] Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus
    Meka, VG
    Gold, HS
    Cooke, A
    Venkataraman, L
    Eliopoulos, GM
    Moellering, RC
    Jenkins, SG
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (04) : 818 - 820
  • [4] Resistance to linezolid in a methicillin-susceptible Staphylococcus aureus clinical isolate without previous exposure to oxazolidinones
    Quiles-Melero, Immaculada
    Garcia-Perea, Adela
    de Pablos, Manuela
    Gomez-Gil, Rosa
    Mingorance, Jesus
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 (03) : 145 - 147
  • [5] Linezolid-Resistant Staphylococcus aureus Strain 1128105, the First Known Clinical Isolate Possessing the cfr Multidrug Resistance Gene
    Locke, Jeffrey B.
    Zuill, Douglas E.
    Scharn, Caitlyn R.
    Deane, Jennifer
    Sahm, Daniel F.
    Denys, Gerald A.
    Goering, Richard V.
    Shaw, Karen J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (11) : 6592 - 6598
  • [6] Phenotypic and Molecular Characterization of Vancomycin and Linezolid Resistance in Clinical Isolates of Staphylococcus aureus
    Aslanimehr, Masoumeh
    Kalhor, Hajar
    Attar, Adeleh
    Barikani, Ameneh
    ARCHIVES OF CLINICAL INFECTIOUS DISEASES, 2024, 19 (03):
  • [7] Resistance to linezolid in staphylococcus aureus before its release
    Akpabie, A
    Naga, H
    Giraud, K
    Al Rahiss, R
    Nadai, S
    PATHOLOGIE BIOLOGIE, 2004, 52 (08): : 493 - 496
  • [8] Emergence of linezolid resistance in a clinical Staphylococcus capitis isolate from Jiangsu Province of China in 2012
    Huang, Yiling
    Xu, Yanling
    Liu, Genyan
    Mei, Yaning
    Xia, Wenying
    Xu, Ting
    Gu, Bing
    Pan, Shiyang
    JOURNAL OF THORACIC DISEASE, 2014, 6 (05) : E48 - E53
  • [9] Detection of resistance to linezolid in Staphylococcus aureus infecting orthopedic patients
    Thool, Vaishali U.
    Bhoosreddy, Girish L.
    Wadher, Bharat J.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (03) : 361 - 364